Lymph Node Dissection and Adrenalectomy in Locally Advanced Renal Cell Carcinoma

Creative Commons License

ÇITAMAK B., Sogutdelen E., AKDOĞAN B.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, sa.3, ss.207-209, 2015 (ESCI) identifier

  • Yayın Türü: Makale / Derleme
  • Basım Tarihi: 2015
  • Doi Numarası: 10.4274/uob.411
  • Dergi Adı: UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI)
  • Sayfa Sayıları: ss.207-209
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

In patients with locally advanced renal cell carcinoma (RCC), simultaneous lymph node dissection (LND) and radical nephrectomy (RN) is controversial. Of the two studies addressing this issue, one randomized study showed no benefit of LND and the other non-randomized one showed better survival for extended LND. In patients with clinically enlarged lymph nodes, LND could be useful for better staging and local control of the disease. Targeted drug therapy trials will probably help us to better define high-risk patients who can benefit from LND in near future. Until now, no randomized study compared RN alone vs. RN plus adrenalectomy yet. Large tumors and upper pole location may help to predict adrenal involvement. However, no clear recommendation is made in the guidelines in 2015.